IHM
CHRS icon

Iguana Healthcare Management’s Coherus Oncology CHRS Stock Holding History

Iguana Healthcare Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-75,000
Closed -$1.27M – 84
2016
Q2 		$1.27M Sell
75,000
-25,000
-25% -$469K 0.52% 62
2016
Q1 		$2.12M Buy
100,000
+25,000
+33% +$410K 0.78% 37
2015
Q4 		$1.72M Buy
+75,000
New +$1.93M 0.57% 50

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Iguana Healthcare Management's CHRS Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Coherus Oncology (CHRS) in Q3 2016, closing a stake of 75,000 shares — an estimated $1.27M sold.

Iguana Healthcare Management first reported a position in CHRS in Q4 2015 and held it in 3 quarters. The position peaked at $2.12M in Q1 2016. 117 funds tracked by Wall St. Rank hold CHRS as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Coherus Oncology position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 75,000 Coherus Oncology shares in Q3 2016, an estimated $1.27M.
  • Iguana Healthcare Management first reported a position in Coherus Oncology in Q4 2015 and held it in 3 quarters.
  • Iguana Healthcare Management's Coherus Oncology position peaked at $2.12M in Q1 2016.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.